Home Quality Improvement Lipid QI Programme Module 3 Lipid Quality Improvement (QI) Programme Module 3: Treatment and Management This programme has been solely funded by Novartis. Novartis were not involved in the development of the programme, content, selection of speakers or their arrangements. All content has been independently developed by PCCS. These modules were filmed in November 2023, which was prior to the publication of the updated NICE guideline NG238. As a result, throughout the videos reference is made to NICE CG181. The information provided in this presentation is for educational purposes only. Prescribing or management decisions made by clinicians are exclusively their own responsibility. The speaker/PCCS bear no responsibility regarding management or prescribing decisions made by others, or otherwise. Downloadable slides Speakers: Prof Raj Thakkar & Dr Jim Moore Please click here to download Resources NHS England, Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD Health Innovation Network, Lipid managament pathway NICE Guidance, Cardiovascular disease: risk assessment and reduction, including lipid modification UCLPartners Proactive Care Framework: Lipid Management including Familial Hypercholesterolaemia For further PCCS resources and guidance, check out our Lipids module on the CVD Academy! Useful links British Heart Foundation, Healthy eating Interested in Putting the Theory into Practice? Read more here. Quality Improvement Programme COVID-19 & CVD QI Programme IntroductionModule 1Module 2Module 3CKD QI Programme IntroductionModule 1Module 2Module 3Module 4Lipid QI ProgrammeModule 1 Module 2Module 3 Module 4 Additional ResourcesHeart Failure QI ProgrammeOberoi Disease Management Digital Audit Platform Explore PCCS Member Benefits